167 related articles for article (PubMed ID: 32569222)
1. Comparison of HAS-BLED with other risk models for predicting the bleeding risk in anticoagulated patients with atrial fibrillation: A PRISMA-compliant article.
Zeng J; Yu P; Cui W; Wang X; Ma J; Zeng C
Medicine (Baltimore); 2020 Jun; 99(25):e20782. PubMed ID: 32569222
[TBL] [Abstract][Full Text] [Related]
2. Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores.
Proietti M; Senoo K; Lane DA; Lip GY
Sci Rep; 2016 Apr; 6():24376. PubMed ID: 27067661
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin.
Senoo K; Proietti M; Lane DA; Lip GY
Am J Med; 2016 Jun; 129(6):600-7. PubMed ID: 26482233
[TBL] [Abstract][Full Text] [Related]
4. Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis.
Caldeira D; Costa J; Fernandes RM; Pinto FJ; Ferreira JJ
J Interv Card Electrophysiol; 2014 Sep; 40(3):277-84. PubMed ID: 25012972
[TBL] [Abstract][Full Text] [Related]
5. The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants.
Lip GYH; Skjøth F; Nielsen PB; Kjældgaard JN; Larsen TB
Am J Med; 2018 May; 131(5):574.e13-574.e27. PubMed ID: 29274754
[TBL] [Abstract][Full Text] [Related]
6. Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial.
Senoo K; Lip GY
Int J Cardiol; 2016 Oct; 221():379-82. PubMed ID: 27409565
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Gao X; Cai X; Yang Y; Zhou Y; Zhu W
Front Cardiovasc Med; 2021; 8():757087. PubMed ID: 34881309
[No Abstract] [Full Text] [Related]
8. Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation.
Guo Y; Zhu H; Chen Y; Lip GYH
Am J Med; 2018 Feb; 131(2):185-192. PubMed ID: 28943382
[TBL] [Abstract][Full Text] [Related]
9. Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores.
Proietti M; Rivera-Caravaca JM; Esteve-Pastor MA; Romiti GF; Marin F; Lip GYH
J Am Heart Assoc; 2018 Sep; 7(18):e009766. PubMed ID: 30371183
[TBL] [Abstract][Full Text] [Related]
10. Comparative validation of HAS-BLED, GARFIELD-AF and ORBIT bleeding risk scores in Asian people with atrial fibrillation treated with oral anticoagulant: A report from the COOL-AF registry.
Chichareon P; Winijkul A; Lip GYH; Krittayaphong R
Br J Clin Pharmacol; 2023 Aug; 89(8):2472-2482. PubMed ID: 36942465
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of HAS-BLED and other bleeding risk assessment tools in predicting major bleeding events in atrial fibrillation: A network meta-analysis.
Chang G; Xie Q; Ma L; Hu K; Zhang Z; Mu G; Cui Y
J Thromb Haemost; 2020 Apr; 18(4):791-801. PubMed ID: 31782613
[TBL] [Abstract][Full Text] [Related]
12. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
O'Brien EC; Simon DN; Thomas LE; Hylek EM; Gersh BJ; Ansell JE; Kowey PR; Mahaffey KW; Chang P; Fonarow GC; Pencina MJ; Piccini JP; Peterson ED
Eur Heart J; 2015 Dec; 36(46):3258-64. PubMed ID: 26424865
[TBL] [Abstract][Full Text] [Related]
13. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.
Roldán V; Marín F; Fernández H; Manzano-Fernandez S; Gallego P; Valdés M; Vicente V; Lip GYH
Chest; 2013 Jan; 143(1):179-184. PubMed ID: 22722228
[TBL] [Abstract][Full Text] [Related]
15. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
16. The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis.
Zhu W; He W; Guo L; Wang X; Hong K
Clin Cardiol; 2015 Sep; 38(9):555-61. PubMed ID: 26418409
[TBL] [Abstract][Full Text] [Related]
17. Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study.
Fauchier L; Chaize G; Gaudin AF; Vainchtock A; Rushton-Smith SK; Cotté FE
Int J Cardiol; 2016 Aug; 217():85-91. PubMed ID: 27179213
[TBL] [Abstract][Full Text] [Related]
18. Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry.
Proietti M; Romiti GF; Vitolo M; Potpara TS; Boriani G; Lip GYH
Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):778-786. PubMed ID: 34555148
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the CHA
Yao X; Gersh BJ; Sangaralingham LR; Kent DM; Shah ND; Abraham NS; Noseworthy PA
Am J Cardiol; 2017 Nov; 120(9):1549-1556. PubMed ID: 28844514
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial.
Proietti M; Hijazi Z; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Lane DA; Oldgren J; Roldan V; Yusuf S; Wallentin L;
J Intern Med; 2018 Mar; 283(3):282-292. PubMed ID: 29044861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
